Arnold Library

Double umbilical cord blood transplantation in patients with hematologic malignancies using a reduced-intensity preparative regimen without antithymocyte globulin.

Ostronoff, F and Milano, F and Gooley, T and Gutman, J A and McSweeney, P and Petersen, F B and Sandmaier, B M and Storb, R and Delaney, C (2012) Double umbilical cord blood transplantation in patients with hematologic malignancies using a reduced-intensity preparative regimen without antithymocyte globulin. Bone marrow transplantation. ISSN 1476-5365 (In Press)

[img] Text
DelaneyBMT_Apr2013.pdf - Accepted Version
Restricted to Repository staff only

Download (357Kb)
Article URL: http://www.nature.com/bmt/journal/vaop/ncurrent/fu...

Abstract

Reduced-intensity conditioning (RIC) regimens in cord blood transplant (CBT) are increasingly utilized for older patients and those with comorbidities. However, the optimal conditioning regimen has not yet been established and remains a significant challenge of this therapeutic approach. Antithymocyte globulin (ATG) has been incorporated into conditioning regimens in order to decrease the risk of graft failure; however, use of ATG is often associated with infusion reactions and risk of post-transplant complications. We report the results of a non-ATG-containing RIC regimen, where patients received 2 Gy TBI unless they were considered to be at higher risk of graft failure, in which case they received 3 Gy of TBI. Thirty patients underwent CBT using this protocol for high-risk hematological malignancies. There was only one case of secondary and no cases of primary graft failure. At 1 year, estimates of non-relapse mortality, OS and PFS were 29%, 53% and 45%, respectively. The cumulative incidences of grade III-IV acute and chronic GVHD were 14% and 18%, respectively. In summary, the results of this study demonstrate that this non-ATG-containing conditioning regimen provides a low incidence of graft failure without increasing regimen-related toxicity.Bone Marrow Transplantation advance online publication, 17 December 2012; doi:10.1038/bmt.2012.243.

Item Type: Article
DOI: 10.1038/bmt.2012.243
PubMed ID: 23241738
NIHMSID: NIHMS468535
Grant Numbers: K23 HL077446, CA18029, CA 78902
FHCRC Divisions: Clinical Research
Depositing User: Library Staff
Date Deposited: 16 Apr 2013 15:54
Last Modified: 16 Apr 2013 15:55
URI: http://authors.fhcrc.org/id/eprint/604

Repository Administrators Only

View Item View Item
Fred Hutchinson Cancer Research Center
1100 Fairview Ave. N. PO Box 19024
Seattle, WA 98109

a 501(c)(3) nonprofit organization.

© Terms of Use & Privacy Policy